ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2020. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $548 | +27300.0% | 19,181 | +19081.0% | 0.00% | – |
| Q1 2023 | $2 | -100.0% | 100 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $1,110,000 | -57.3% | 75,047 | +34.9% | 0.01% | -45.5% |
| Q2 2020 | $2,601,000 | +513.4% | 55,642 | +78.3% | 0.01% | +450.0% |
| Q1 2020 | $424,000 | +160.1% | 31,206 | +108.2% | 0.00% | +100.0% |
| Q4 2019 | $163,000 | – | 14,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |